ETHyR Biotech
ETHyR Biotech is developing an innovative enzyme-free technology for DNA sequence detection. This is based on a patented DNA chain reaction that is isothermal and provides rapid, sensitive, cheap and automatable or point of care solutions for personalized medicine, disease outbreak detection, drug targeting, research, and diagnostics. This technology is targeted at clinical pathology labs, scientific researchers, healthcare professionals, disease control institutions, and households in a $4 billion growing market.